会议皇冠假日酒店

14:30	16:00	突破NASH的管理	成军 AHN Sang Hoon
		Breakthrough for the Management of NASH	CHENG Jun AHN Sang Hoon
14:30		NASH的管理	南月敏
		Diagnosis of NASH	NAN Yuemin
14:50		NASH的药物治疗	范建高
		Medical Treatment of NASH	FAN Jiangao
15:10		NASH和营养治疗	黄丽虹
		NASH and Nutritional Therapy	Grace WONG
15:30		难治性NASH的处理	Diana ALCANTARA-PAYAWAL
		Management of Refractory NASH	Diana ALCANTARA-PAYAWAL
16:50		讨论
		Discussion
16:00	17:30	Antifibrotic治疗和肝纤维化的管理	辛绍杰 Diana ALCANTARA-PAYAWAL
		Antifibrotic Treatment and the Management of Liver Fibrosis	XIN Shaojie Diana ALCANTARA-PAYAWAL
16:00		乙肝病毒治疗肝纤维化的判决	AHN Sang Hoon
		HBV therapy on reveral of hepatic fibrosis	AHN Sang Hoon
16:20		无创性肝纤维化：现状和未来的发展	陈国凤
		Non-invasive Diagnosis of Liver Fibrosis: Current Status and Future Development	JIA Jidong
16:40		改善肝纤维化肝活检的性能评估	汪艳
		Improving performance of liver biopsy in fibrosis assessment	WANG Yan
17:00		肝纤维化的潜在治疗方法和评价	尤红
		Potential Therapies for Hepatic Fibrosis and Evaluation	YOU Hong
17:20	17:45	讨论
		Discussion
17:45	18:30	学术研讨会1
		Satellite Symposium 1

09:00	09:30	开幕式
		Opening Ceremony
09:30	10:00	专题报告 1	Masao OMATA
		State-of-the Art Lecture 1	Masao OMATA
09:30		乙型肝炎病毒和丙型肝炎病毒联动护理得现状	Mindie H. NGUYEN
		Current State of HBV and HCV Linkage to Care	Mindie H. NGUYEN
10:00	10:15	壁报交流／茶歇
		Poster Session / Coffee Break
10:15	11:45	主题讨论会 1 丙型肝炎病毒管理有待解决的问题	徐小元 Mindie H. NGUYEN
		Official Symposium 1 Unresolved Issues of HCV Mangement	XU Xiao Yuan Mindie H. NGUYEN
10:15		丙型肝炎的治疗方法：亚太地区的临床试验和临床 设置	Masao OMATA
		Treatment Algorithm of HCV: Guidelines,Clinical Trials and Clinical Settings in Asia Pacific	Masao OMATA
10:35		丙型肝炎的治疗法则：指南，临床试验和临床设置在中国	魏来
		Treatment Algorithm of HCV: Guidelines,Clinical Trials and Clinical Settings in China	WEI Lai
10:55		对丙型肝炎患者的管理决策：DAAs或干扰素治疗或等待	窦晓光
		Decision Making for the Management of Hepatitis C Patients: Treat or Wait and DAAs or Interferon	DOU Xiaoguang
11:15		丙型肝炎治疗的挑战和展望	廖家杰
		Response guided therapy in DAAs era	Sanjeev ARORA
11:35
		Discussion
11:45	14:00	对丙型肝炎患者的管理决策：DAAs或干扰素治 疗或等待
		Poster Session / Lunch
12:00	12:45	学术研讨会 2
		Satellite Symposium 2
13:00	13:45	学术研讨会 3
		Satellite Symposium 3
14:00	14:30	专题报告 2	宁琴
		State-of-the Art Lecture 2	NING Qin
14:00		管理慢性乙型肝炎：预防母婴传播乙型肝炎	Calvin Q. PAN
		Management of CHB: Strength and Limitations of Current Treatment Options and The Hope of Future Therapeutic Strategies	Calvin Q. PAN
14:30	16:00	主题讨论会 2 走近乙型肝炎病毒的免疫学和病毒学	Calvin Q. PAN
		Official Symposium 2 Immunology and Virology Approaches to HBV	Calvin Q. PAN
14:30		乙型肝炎和丁型肝炎的合并感染的管理：治疗的新选择	Jeffery GLENN
		Management of Hepatitis B and D Coinfection: Novel Therapeutic Options	Jeffery GLENN
14:50		HBeAg阳性患者的免疫持续控制	宁琴
		Sustained Immune Control in HBeAg-positive Patients	NING Qin
15:10		乙型肝炎与先天免疫	Aleem SIDDIQUI
		Hepatitis B and innate immunity	Aleem SIDDIQUI
15:30		靶向乙型肝炎病毒的潜在新治疗策略	鲁凤鸣
		Potential new therapeutic strategies targeting HBV	LU Fengmin
15:50		讨论
		Discussion
16:15	17:00	学术研讨会 4
		Satellite Symposium 4
17:15	18:00	学术研讨会 5
		Satellite Symposium 5

09:00	09:30	专题报告 3	HAN Kwang-Hyub
		State-of-the Art Lecture 3	HAN Kwang-Hyub
09:00		治疗肝癌的新目标	Jack R. WANDS
		Novel Therapeutic Target for HCC	Jack R. WANDS
09:30	09:45	壁报交流／茶歇
		Poster Session / Coffee Break
10:00	11:30	学术研讨会 3 通过管理慢性肝病预防肝癌	NING Qin Jack R. WANDS
		Official Symposium 3 Management of Non-Viral Hepatitis	宁琴 Jack R. WANDS
10:00		自身免疫性肝病	韩英
		Autoimmune Liver Disease	HAN Ying
10:20		聚乙二醇干扰素和NUC治疗HBeAg阳性慢性乙型肝炎的疗效预测	孙剑
		Management of Liver Cirrhosis and End-Stage Liver Disease	SUN Jian
10:40		预防肝癌复发	Rosmawati MOHAMED
		Prevention of HCC and Recurrence	Rosmawati MOHAMED
11:00		肝细胞癌：诊断和治疗策略	HAN Kwang-Hyub
		HCC: Diganosis and Treatment Strategy	HAN Kwang-Hyub
11:20		讨论
		Discussion
11:30	12:30	口头报告	于岩岩
		Oral Presentation